Skip to content

The difference of combination therapy in uncontrolled hypertension

The difference of combination therapy in uncontrolled hypertension - The difference of combination therapy in uncontrolled hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014372
Enrollment
200
Registered
2014-07-01
Start date
2011-10-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

One group taken the combination ARB with diuretics (Ecard HD(R)) One group taken the combination ARB with diuretics (Unisia HD(R))

Sponsors

Jichi Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with diagnosed hypertension in our hospital and collaborate research institutes. (Inclusion criteria) 1)Patients taken each calcium blocker or ARB, or patients with alfa blocker or beta blocker adding in each calcium blocker or ARB. 2)In spite of performing life modification (diet and exercise) and the above medication, their clinic BP is above 140/90mmHg.

Exclusion criteria

Exclusion criteria: (Exclusion criteria) 1)Allergy of these drugs in this study 2)Anuria or hemodialysis 3)Acute renal failure 4)Significant low sodium and potassium 5)Pregnancy or possibility of pregnancy 6)Not given informed consent (adolescents, dementia) 7)In case the physicians decide to be inappropriate in this study

Design outcomes

Primary

MeasureTime frame
-change in blood pressure at home blood pressure measurement -change in augmentation index

Secondary

MeasureTime frame
-change in blood pressure (BP) at 24hr BP monitoring and clinic BP -change in NTproBNP, hsCRP, hsTnT, cystatin C, VEGF-C, LDL cholesterol, triglyceride, HDL cholesterol, BUN, creatinine, potassium, sodium, glucose, urine-sodium, and urinary albumin creatinine ratio

Countries

Japan

Contacts

Public ContactSatoshi Hoshide

Jichi Medical University School of Medicine Division of Cardiovascular Medicine, Department of Medicine

hoshide@jichi.ac.jp0285-58-7344

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026